This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fisher, N. D. L. Articles by Seely, E. W. Search for Related Content PubMed PubMed Citation Articles by Fisher, N. D. L. Articles by Seely, E. W. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure

(Hypertension. 1997;29:980-985.)
© 1997 American Heart Association, Inc.

Articles

Age, Gender, and Non-modulation

A Sexual Dimorphism in Essential Hypertension

Naomi D. L. Fisher; Claudio Ferri; Cesare Bellini; Anna Santucci; Ray Gleason; Gordon H. Williams; Norman K. Hollenberg; ; Ellen W. Seely

From the Departments of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, Mass, and Università La Sapienza, Rome, Italy.

Correspondence to Naomi D.L. Fisher, Endocrine-Hypertension Division, Brigham and Women's Hospital, 221 Longwood Ave, Boston, MA 02115. E-mail ndfisher{at}bics.bwh.harvard.edu

Abstract The angiotensinogen gene is one of the very few related by linkage analysis to human hypertension, but the linkage has been consistently shown only among males. Moreover, polymorphisms in this gene predict an abnormal renal responsiveness to angiotensin II, a feature of non-modulation, but again, only among males. To pursue these related bridges between genetics and physiology, we evaluated the effects of sex on a second feature of non-modulation, the aldosterone response to infused angiotensin II during low sodium balance. We tested the resultant hypothesis—that non-modulation would be less frequent in women—by conducting identical protocols on 225 hypertensive inpatients (70 women, 155 men). Non-modulation was strikingly less frequent among women (26%; 95% confidence interval, 16% to 37%) than men (49%; 95% confidence interval, 40% to 57%) (P=.001). We tested the hypothesis that sex steroids play a role by comparing young, premenopausal women (<35 years) with women who were perimenopausal (45 to 55 years) and postmenopausal (>55 years). Among the youngest women, the frequency of non-modulation was only 7%, significantly less than in young men (41%, P=.02). A steady increase in non-modulation frequency accompanied advancing age in women, reaching 47% in those older than 55 years, equal to the fraction of men affected. Age influenced non-modulation frequency in men far less. We conclude that a striking sex difference underlies the non-modulation phenotype and that female sex hormones may confer protection against a genotypic predisposition in women. This "override" of genotype, manifest by a very low frequency of non-modulation in young women, may participate in their known protection against cardiovascular disease.

Key Words: angiotensinogen • angiotensin II • sodium • genotype

This article has been cited by other articles:

				M. P. Hutchens, J. Dunlap, P. D. Hurn, and P. O. Jarnberg Renal Ischemia: Does Sex Matter? Anesth. Analg., July 1, 2008; 107(1): 239 - 249. [Abstract] [Full Text] [PDF]

				C. J. O'Donnell, S. Demissie, M. Kimura, D. Levy, J. P. Gardner, C. White, R. B. D'Agostino, P. A. Wolf, J. Polak, L. A. Cupples, et al. Leukocyte Telomere Length and Carotid Artery Intimal Medial Thickness: The Framingham Heart Study Arterioscler Thromb Vasc Biol, June 1, 2008; 28(6): 1165 - 1171. [Abstract] [Full Text] [PDF]

				N. Kosachunhanun, S. C. Hunt, P. N. Hopkins, R. R. Williams, X. Jeunemaitre, P. Corvol, C. Ferri, R. M. Mortensen, N. K. Hollenberg, and G. H. Williams Genetic Determinants of Nonmodulating Hypertension Hypertension, November 1, 2003; 42(5): 901 - 908. [Abstract] [Full Text] [PDF]

				T. H. Le, H.-S. Kim, A. M. Allen, R. F. Spurney, O. Smithies, and T. M. Coffman Physiological Impact of Increased Expression of the AT1 Angiotensin Receptor Hypertension, October 1, 2003; 42(4): 507 - 514. [Abstract] [Full Text] [PDF]

				N. D.L. Fisher, S. Hurwitz, X. Jeunemaitre, P. N. Hopkins, N. K. Hollenberg, and G. H. Williams Familial Aggregation of Low-Renin Hypertension Hypertension, April 1, 2002; 39(4): 914 - 918. [Abstract] [Full Text] [PDF]

				K. F. Hilgers, C. Delles, R. Veelken, and R. E. Schmieder Angiotensinogen Gene Core Promoter Variants and Non-Modulating Hypertension Hypertension, December 1, 2001; 38(6): 1250 - 1254. [Abstract] [Full Text] [PDF]

				N. D.L. Fisher, S. Hurwitz, X. Jeunemaitre, D. A. Price, G. H. Williams, and N. K. Hollenberg Adrenal Response to Angiotensin II in Black Hypertension: Lack of Sexual Dimorphism Hypertension, September 1, 2001; 38(3): 373 - 378. [Abstract] [Full Text] [PDF]

				A. Aviv Hypothesis : Pulse Pressure and Human Longevity Hypertension, April 1, 2001; 37(4): 1060 - 1066. [Abstract] [Full Text] [PDF]

				A. Benetos, K. Okuda, M. Lajemi, M. Kimura, F. Thomas, J. Skurnick, C. Labat, K. Bean, and A. Aviv Telomere Length as an Indicator of Biological Aging : The Gender Effect and Relation With Pulse Pressure and Pulse Wave Velocity Hypertension, February 1, 2001; 37(2): 381 - 385. [Abstract] [Full Text] [PDF]

				M. Giacche, A. Vuagnat, S. C. Hunt, P. N. Hopkins, N. D. L. Fisher, M. Azizi, P. Corvol, G. H. Williams, and X. Jeunemaitre Aldosterone Stimulation by Angiotensin II : Influence of Gender, Plasma Renin, and Familial Resemblance Hypertension, March 1, 2000; 35(3): 710 - 716. [Abstract] [Full Text] [PDF]

				A. Ylitalo, K. E. J. Airaksinen, A. Hautanen, M. Kupari, M. Carson, J. Virolainen, M. Savolainen, H. Kauma, Y. A. Kesaniemi, P. C. White, et al. Baroreflex sensitivity and variants of the renin angiotensin system genes J. Am. Coll. Cardiol., January 1, 2000; 35(1): 194 - 200. [Abstract] [Full Text] [PDF]

				L. P. Audoly, S. L. Tilley, J. Goulet, M. Key, M. Nguyen, J. L. Stock, J. D. McNeish, B. H. Koller, and T. M. Coffman Identification of specific EP receptors responsible for the hemodynamic effects of PGE2 Am J Physiol Heart Circ Physiol, September 1, 1999; 277(3): H924 - H930. [Abstract] [Full Text] [PDF]

				N. D. L. Fisher, S. Hurwitz, C. Ferri, X. Jeunemaitre, N. K. Hollenberg, and G. H. Williams Altered Adrenal Sensitivity to Angiotensin II in Low-Renin Essential Hypertension Hypertension, September 1, 1999; 34(3): 388 - 394. [Abstract] [Full Text] [PDF]

				M. Horiguchi, M. Kimura, J. Skurnick, and A. Aviv Parameters of Lymphocyte Na+-Ca2+ Regulation and Blood Pressure : The Gender Effect Hypertension, November 1, 1998; 32(5): 869 - 874. [Abstract] [Full Text] [PDF]

				T. Rankinen, T. Rice, A. S. Leon, J. S. Skinner, J. H. Wilmore, D. C. Rao, and C. Bouchard G protein {beta}3 polymorphism and hemodynamic and body composition phenotypes in the HERITAGE Family Study Physiol Genomics, February 28, 2002; 8(2): 151 - 157. [Abstract] [Full Text] [PDF]

				P. N. Hopkins, S. C. Hunt, X. Jeunemaitre, B. Smith, D. Solorio, N. D.L. Fisher, N. K. Hollenberg, and G. H. Williams Angiotensinogen Genotype Affects Renal and Adrenal Responses to Angiotensin II in Essential Hypertension Circulation, April 23, 2002; 105(16): 1921 - 1927. [Abstract] [Full Text] [PDF]